The ARF tumor suppressor inhibits BCL6-mediated transcriptional repression

Biochemical and Biophysical Research Communications

Volumn 326, Issue 1, 2004, Pages 242-248

  Suzuki, Hiroaki ^a,b   Kurita, Megumi ^a   Mizumoto, Kiyohisa ^b   Moriyama, Masatsugu ^a   Aiso, Sadakazu ^c   Nishimoto, Ikuo ^a   Matsuoka, Masaaki ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c OITA UNIVERSITY   (Japan)

Author keywords

ARF; BCL6; p14 ARF; p19 ARF; Tumor suppressor

Indexed keywords

ARF PROTEIN; PROTEIN BCL 6; PROTEIN P14; PROTEIN P19;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ANIMALS; BINDING SITES; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA-BINDING PROTEINS; DOWN-REGULATION; HUMANS; MICE; OSTEOSARCOMA; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-6; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEINS;

EID: 9644268124     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.11.016     Document Type: Article

References (38)

1. D.E. Quelle, F. Zindy, R.A. Ashmun, and C.J. Sherr Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest Cell 83 1995 993 1000
2. T. Kamijo, F. Zindy, M.F. Roussel, D.E. Quelle, J.R. Downing, R.A. Ashmun, G. Grosveld, and C.J. Sherr Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF Cell 91 1997 649 659
3. S.W. Lowe, and C.J. Sherr Tumor suppression by Ink4a-Arf: progress and puzzles Curr. Opin. Genet. Dev. 13 2003 77 83
4. J.D. Weber, J.R. Jeffers, J.E. Rehg, D.H. Randle, G. Lozano, M.F. Roussel, C.J. Sherr, and G.P. Zambetti p53-independent functions of the p19(ARF) tumor suppressor Genes Dev. 14 2000 2358 2365
5. K. Tsuji, K. Mizumoto, H. Sudo, K. Kouyama, E. Ogata, and M. Matsuoka p53-independent apoptosis is induced by the p19ARF tumor suppressor Biochem. Biophys. Res. Commun. 295 2002 621 629
6. B. Eymin, C. Leduc, J.L. Coll, E. Brambilla, and S. Gazzeri p14ARF induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice Oncogene 22 2003 1822 1835
7. M. Matsuoka, M. Kurita, H. Sudo, K. Mizumoto, I. Nishimoto, and E. Ogata Multiple domains of the mouse p19ARF tumor suppressor are involved in p53-independent apoptosis Biochem. Biophys. Res. Commun. 301 2003 1000 1010
8. Y. Nakazawa, T. Kamijo, K. Koike, and T. Noda ARF tumor suppressor induces mitochondria-dependent apoptosis by modulation of mitochondrial Bcl-2 family proteins J. Biol. Chem. 278 2003 27888 27895
9. H. Suzuki, M. Kurita, K. Mizumoto, I. Nishimoto, E. Ogata, and M. Matsuoka p19ARF-induced p53-independent apoptosis largely occurs through BAX Biochem. Biophys. Res. Commun. 312 2003 1273 1277
10. M.L. Kuo, E.J. Duncavage, R. Mathew, W. den Besten, D. Pei, D. Naeve, T. Yamamoto, C. Cheng, C.J. Sherr, and M.F. Roussel Arf induces p53-dependent and -independent antiproliferative genes Cancer Res. 63 2003 1046 1053
11. B. Eymin, L. Kanaryan, P. Seite, C. Brambilla, E. Brambilla, C.J. Larsen, and S. Gazzeri Human ARF binds E2F1 and inhibits its transcriptional activity Oncogene 20 2001 1033 1041
12. F. Martelli, T. Hamilton, D.P. Silver, N.E. Sharpless, N. Bardeesy, M. Rokas, R.A. DePinho, D.M. Livingston, and S.R. Grossman p19ARF targets certain E2F species for degradation Proc. Natl. Acad. Sci. USA. 98 2001 4455 4460
13. M. Vivo, R.A. Calogero, F. Sansone, V. Calabro, T. Parisi, L. Borrelli, S. Saviozzi, and G. La Mantia The human tumor suppressor arf interacts with spinophilin/neurabin II, a type 1 protein-phosphatase-binding protein J. Biol. Chem. 276 2001 14161 14169
14. T. Sugihara, S.C. Kaul, J. Kato, R.R. Reddel, H. Nomura, and R. Wadhwa Pex19p dampens the p19ARF-p53-p21WAF1 tumor suppressor pathway J. Biol. Chem. 276 2001 18649 18652
15. L. Karayan, L.F. Riou, P. Seite, J. Migeon, A. Cantereau, and C.J. Larsen Human ARF protein interacts with Topoisomerase I and stimulates its activity Oncogene 20 2001 836 848
16. K. Fatyol, and A.A. Szalay The p14ARF tumor suppressor protein facilitates nucleolar sequestration of hypoxia-inducible factor-1 (HIF-1) and inhibits HIF-1-mediated transcription J. Biol. Chem. 276 2001 28421 28429
17. L. Zhao, T. Samuels, S. Winckler, C. Korgaonkar, V. Tompkins, M.C. Horne, and D.E. Quelle Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways Mol. Cancer Res. 1 2003 195 206
18. S. Rocha, K.J. Campbell, and N.D. Perkins p53- and Mdm2-independent repression of NF-kappa B transactivation by the ARF tumor suppressor Mol. Cell 12 2003 15 25
19. A.L. Dent, F.H. Vasanwala, and L.M. Toney Regulation of gene expression by the proto-oncogene BCL-6 Crit. Rev. Oncol. Hematol. 41 2002 1 9
20. T. Fukuda, T. Yoshida, S. Okada, M. Hatano, T. Miki, K. Ishibashi, S. Okabe, H. Koseki, S. Hirosawa, M. Taniguchi, N. Miyasaka, and T. Tokuhisa Disruption of the Bcl6 gene results in an impaired germinal center formation J. Exp. Med. 186 1997 439 448
21. B.H. Ye, G. Cattoretti, Q. Shen, J. Zhang, N. Hawe, R. de Waard, C. Leung, M. Nouri-Shirazi, A. Orazi, R.S. Chaganti, P. Rothman, A.M. Stall, P.P. Pandolfi, and R. Dalla-Favera The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation Nat. Genet. 16 1997 161 170
22. B.W. Baron, J. Anastasi, A. Montag, D. Huo, R.M. Baron, T. Karrison, M.J. Thirman, S.K. Subudhi, R.K. Chin, D.W. Felsher, Y.X. Fu, T.W. McKeithan, and J.M. Baron The human BCL6 transgene promotes the development of lymphomas in the mouse Proc. Natl. Acad. Sci. USA 101 2004 14198 141203
23. O. Albagli-Curiel Ambivalent role of BCL6 in cell survival and transformation Oncogene 22 2003 507 516
24. K. Tsuji, K. Mizumoto, T. Yamochi, I. Nishimoto, and M. Matsuoka Differential effect of ik3-1/cables on p53- and p73-induced cell death J. Biol. Chem. 277 2002 2951 2957
25. T. Yamochi, Y. Kaneita, T. Akiyama, S. Mori, and M. Moriyama Adenovirus-mediated high expression of BCL-6 in CV-1 cells induces apoptotic cell death accompanied by down-regulation of BCL-2 and BCL-X(L) Oncogene 18 1999 487 494
26. T. Onizuka, M. Moriyama, T. Yamochi, T. Kuroda, A. Kazama, N. Kanazawa, K. Sato, T. Kato, H. Ota, and S. Mori BCL-6 gene product, a 92- to 98-kDa nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts Blood 86 1995 28 37
27. S. Llanos, P.A. Clark, J. Rowe, and G. Peters Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus, Nat. Cell Biol. 3 2001 445 452
28. K.D. Huynh, W. Fischle, E. Verdin, and V.J. Bardwell BCoR, a novel corepressor involved in BCL-6 repression Genes Dev. 14 2000 1810 1823
29. T. Kumagai, T. Miki, M. Kikuchi, T. Fukuda, N. Miyasaka, R. Kamiyama, and S. Hirosawa The proto-oncogene Bc16 inhibits apoptotic cell death in differentiation-induced mouse myogenic cells Oncogene 18 1999 467 475
30. T. Yoshida, T. Fukuda, M. Hatano, H. Koseki, S. Okabe, K. Ishibashi, S. Kojima, M. Arima, I. Komuro, G. Ishii, T. Miki, T. Hirosawa, N. Miyaswa, M. Taniguchi, T. Ochiai, K. Isono, and T. Tokuhisa The role of Bcl6 in mature cardiac myocytes Cardiovasc. Res. 42 1999 670 679
31. S. Kojima, M. Hatano, S. Okada, T. Fukuda, Y. Toyama, S. Yuasa, H. Ito, and T. Tokuhisa Testicular germ cell apoptosis in Bcl6-deficient mice Development 128 2001 57 65
32. B.W. Baron, J. Anastasi, M.J. Thirman, Y. Furukawa, S. Fears, D.C. Kim, F. Simone, M. Birkenbach, A. Montag, A. Sadhu, N. Zeleznik-Le, and T.W. McKeithan The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis Proc. Natl. Acad. Sci. USA 99 2002 2860 2865
33. T. Kurosu, T. Fukuda, T. Miki, and O. Miura BCL6 overexpression prevents increase in reactive oxygen species and inhibits apoptosis induced by chemotherapeutic reagents in B-cell lymphoma cells Oncogene 22 2003 4459 4468
34. S. Kusam, F.H. Vasanwala, and A.L. Dent Transcriptional repressor BCL-6 immortalizes germinal center-like B cells in the absence of p53 function Oncogene 23 2004 839 844
35. O. Albagli, D. Lantoine, S. Quief, F. Quignon, C. Englert, J.P. Kerckaert, D. Montarras, C. Pinset, and C. Lindon Overexpressed BCL6 (LAZ3) oncoprotein triggers apoptosis, delays S phase progression and associates with replication foci Oncogene 18 1999 5063 5075
36. A.L. Shaffer, X. Yu, Y. He, J. Boldrick, E.P. Chan, and L.M. Staudt BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control Immunity 13 2000 199 212
37. T.T. Lang, D. Dowbenko, A. Jackson, L. Toney, D.A. Lewin, A.L. Dent, and L.A. Lasky The forkhead transcription factor AFX activates apoptosis by induction of the BCL-6 transcriptional repressor J. Biol. Chem. 277 2002 14255 14265
38. A. Shvarts, T.R. Brummelkamp, F. Scheeren, E. Koh, G.Q. Daley, H. Spits, and R. Bernards A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling Genes Dev. 16 2002 681 686